These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

431 related articles for article (PubMed ID: 33521730)

  • 1. Co-infections: testing macrolides for added benefit in patients with COVID-19.
    Sterenczak KA; Barrantes I; Stahnke T; Stachs O; Fuellen G; Undre N
    Lancet Microbe; 2020 Dec; 1(8):e313. PubMed ID: 33521730
    [No Abstract]   [Full Text] [Related]  

  • 2. Survey of antibiotic and antifungal prescribing in patients with suspected and confirmed COVID-19 in Scottish hospitals.
    Seaton RA; Gibbons CL; Cooper L; Malcolm W; McKinney R; Dundas S; Griffith D; Jeffreys D; Hamilton K; Choo-Kang B; Brittain S; Guthrie D; Sneddon J
    J Infect; 2020 Dec; 81(6):952-960. PubMed ID: 32987097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Macrolides for patients with COVID-19 and concurrent pertussis infection.
    Kow CS; Hasan SS
    Diagn Microbiol Infect Dis; 2021 Feb; 99(2):115245. PubMed ID: 33130501
    [No Abstract]   [Full Text] [Related]  

  • 4. Understanding the role of bacterial and fungal infection in COVID-19.
    Rawson TM; Wilson RC; Holmes A
    Clin Microbiol Infect; 2021 Jan; 27(1):9-11. PubMed ID: 32979569
    [No Abstract]   [Full Text] [Related]  

  • 5. Bacterial and Fungal Coinfection in Individuals With Coronavirus: A Rapid Review To Support COVID-19 Antimicrobial Prescribing.
    Rawson TM; Moore LSP; Zhu N; Ranganathan N; Skolimowska K; Gilchrist M; Satta G; Cooke G; Holmes A
    Clin Infect Dis; 2020 Dec; 71(9):2459-2468. PubMed ID: 32358954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bacterial co-infections with SARS-CoV-2.
    Mirzaei R; Goodarzi P; Asadi M; Soltani A; Aljanabi HAA; Jeda AS; Dashtbin S; Jalalifar S; Mohammadzadeh R; Teimoori A; Tari K; Salari M; Ghiasvand S; Kazemi S; Yousefimashouf R; Keyvani H; Karampoor S
    IUBMB Life; 2020 Oct; 72(10):2097-2111. PubMed ID: 32770825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Underestimation of co-infections in COVID-19 due to non-discriminatory use of antibiotics.
    Chang CY; Chan KG
    J Infect; 2020 Sep; 81(3):e29-e30. PubMed ID: 32628960
    [No Abstract]   [Full Text] [Related]  

  • 8. SARS-CoV-2 Omicron (B.1.1.529) Variant: Corticosteroids Treatment/Respiratory Coinfection.
    Elkoshi Z
    Front Immunol; 2022; 13():856072. PubMed ID: 35309339
    [No Abstract]   [Full Text] [Related]  

  • 9. Repurposing of antibiotics for clinical management of COVID-19: a narrative review.
    Yacouba A; Olowo-Okere A; Yunusa I
    Ann Clin Microbiol Antimicrob; 2021 May; 20(1):37. PubMed ID: 34020659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibiotic use in patients with Coronavirus disease 2019 (COVID-19): outcomes and associated factors.
    Milas S; Poncelet A; Buttafuoco F; Pardo A; Lali SE; Cherifi S
    Acta Clin Belg; 2022 Jun; 77(3):579-587. PubMed ID: 33896399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Co-infection of influenza B virus and SARS-CoV-2: A case report from Taiwan.
    Huang BR; Lin YL; Wan CK; Wu JT; Hsu CY; Chiu MH; Huang CH
    J Microbiol Immunol Infect; 2021 Apr; 54(2):336-338. PubMed ID: 32646801
    [No Abstract]   [Full Text] [Related]  

  • 12. Could the COVID-19 pandemic aggravate antimicrobial resistance?
    Rossato L; Negrão FJ; Simionatto S
    Am J Infect Control; 2020 Sep; 48(9):1129-1130. PubMed ID: 32603851
    [No Abstract]   [Full Text] [Related]  

  • 13. COVID-19 pneumonia and the appropriate use of antibiotics.
    Ginsburg AS; Klugman KP
    Lancet Glob Health; 2020 Dec; 8(12):e1453-e1454. PubMed ID: 33188730
    [No Abstract]   [Full Text] [Related]  

  • 14. Effectiveness of Streptococcus Pneumoniae Urinary Antigen Testing in Decreasing Mortality of COVID-19 Co-Infected Patients: A Clinical Investigation.
    Desai A; Santonocito OG; Caltagirone G; Kogan M; Ghetti F; Donadoni I; Porro F; Savevski V; Poretti D; Ciccarelli M; Martinelli Boneschi F; Voza A
    Medicina (Kaunas); 2020 Oct; 56(11):. PubMed ID: 33138045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Streptococcus pneumoniae coinfection in hospitalised patients with COVID-19.
    Anton-Vazquez V; Clivillé R
    Eur J Clin Microbiol Infect Dis; 2021 Jun; 40(6):1353-1355. PubMed ID: 33462723
    [No Abstract]   [Full Text] [Related]  

  • 16. Bacterial coinfection in critically ill COVID-19 patients with severe pneumonia.
    Elabbadi A; Turpin M; Gerotziafas GT; Teulier M; Voiriot G; Fartoukh M
    Infection; 2021 Jun; 49(3):559-562. PubMed ID: 33393065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tetracycline plus macrolide: A potential therapeutic regimen for COVID-19?
    Ohe M; Furuya K; Goudarzi H
    Biosci Trends; 2021 Jan; 14(6):467-468. PubMed ID: 33390423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of Antimicrobial Drug Use and Concurrent Infections During Hospitalization of Patients With COVID-19 in Japan.
    Komagamine J; Yabuki T; Matsumoto K; Tanaka N
    JAMA Netw Open; 2022 Feb; 5(2):e220040. PubMed ID: 35179589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Appropriate use of antimicrobial therapy for COVID-19 co-infection.
    Lai CC; Yu WL
    Immunotherapy; 2021 Sep; 13(13):1067-1070. PubMed ID: 34114473
    [No Abstract]   [Full Text] [Related]  

  • 20. The Elephant in the Room: Secondary Infections and Antimicrobial Use in Patients With COVID-19.
    Ripa M; Mastrangelo A
    Chest; 2021 Aug; 160(2):387-388. PubMed ID: 34366018
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 22.